Adaptimmune(ADAP) Newsfile·2025-03-12 20:54Core Viewpoint - Adaptimmune Therapeutics plc is set to report its financial results and business updates for Q4 and the full year of 2024 on March 20, 2025, before US markets open, followed by a live webcast [1]. Company Overview - Adaptimmune is a clinical-stage biopharmaceutical company focused on developing cell therapies aimed at treating solid tumor cancers [3]. - The company utilizes a unique engineered T-cell receptor (TCR) platform to create T-cells that target and destroy various solid tumor types [3]. Upcoming Events - The financial results announcement will be accompanied by a live webcast at 8:00 a.m. EDT on the same day [1]. - Investors can access the press release in the investor section of Adaptimmune's corporate website and participate in the live webcast [2].